Publication | Closed Access

Acute treatment with TrkB agonist LM22A-4 confers neuroprotection and preserves myelin integrity in a mouse model of pediatric traumatic brain injury

Acute TreatmentTraumatic Brain InjuryLm22a-4 Confers NeuroprotectionMedicineBrain InjuryNeurologyNeuroprotectionNeuroscienceNeuroimmunologyMouse ModelNeuroinflammation